檢索結果

在您的搜尋 主題建議
Refine Results
  1. 1
    Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the <scp>TODAY</scp> clinical trial

    Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the <...

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population

    Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population 由 Sonia Garg, James A. de Lemos, Colby Ayers, Michel G. Khouri, Ambarish Pandey, Jarett D. Berry, Ronald M. Peshock, Mark H. Drazner

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Adipose Tissue Lipolysis Promotes Exercise-induced Cardiac Hypertrophy Involving the Lipokine C16:1n7-Palmitoleate

    Adipose Tissue Lipolysis Promotes Exercise-induced Cardiac Hypertrophy Involving the Lipokine C16:1n7-Palmitoleate 由 Anna Foryst‐Ludwig, Michael C. Kreißl, Verena Benz, Sarah Brix, Elia Smeir, Zsófia Bán, Elżbieta Januszewicz, Janek Salatzki, Jana Grune, Annekatrin Schwanstecher, Annelie Blumrich, Andreas Schirbel, Robert Klopfleisch, Michael Rothe, K. G. Blume, Martin Halle, Bernd Wolfarth, Erin E. Kershaw, Ulrich Kintscher

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Ventricular Arrhythmias in Hypertensive Left Ventricular Hypertrophy

    Ventricular Arrhythmias in Hypertensive Left Ventricular Hypertrophy 由 James M. McLenachan, Henry J. Dargie

    出版 1990
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Differences in Fabry Cardiomyopathy Between Female and Male Patients

    Differences in Fabry Cardiomyopathy Between Female and Male Patients 由 Markus Niemann, Sebastian Herrmann, Kai Hu, Frank Breunig, Jörg Strotmann, Meinrad Beer, Wolfram Machann, Wolfram Voelker, Georg Ertl, Christoph Wanner, Frank Weidemann

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Infiltrative Cardiovascular Diseases

    Infiltrative Cardiovascular Diseases 由 James B. Seward, Grace Casaclang‐Verzosa

    出版 2010
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Influence of Physical Activity on Hypertension and Cardiac Structure and Function

    Influence of Physical Activity on Hypertension and Cardiac Structure and Function 由 Sheila M. Hegde, Scott D. Solomon

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Entendendo a disfunção diastólica assintomática na prática clínica

    Entendendo a disfunção diastólica assintomática na prática clínica 由 Evandro Tinoco Mesquita, Antônio José Lagoeiro Jorge

    出版 2013
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Is Daytime Systolic Load an Important Risk Factor for Target Organ Damage in Pediatric Hypertension?

    Is Daytime Systolic Load an Important Risk Factor for Target Organ Damage in Pediatric Hypertension? 由 Seçil Çonkar, Ebru Yılmaz, Şükriye Hacıkara, Sibel Bozabalı, Sevgı Mır

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy∗∗∗∗A list of participating hospitals, central agencies and personnel appears in reference 26.

    Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrop... 由 Miguel A. Quiñones, Barry Greenberg, Helen A. Kopelen, Chris Koilpillai, Marian C. Limacher, Daniel M. Shindler, Brent J. Shelton, Debra H. Weiner

    出版 2000
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Impact of Donor Left Ventricular Hypertrophy on Survival After Heart Transplant

    Impact of Donor Left Ventricular Hypertrophy on Survival After Heart Transplant 由 Omar Wever‐Pinzon, Gregory J. Stoddard, Stavros G. Drakos, Edward M. Gilbert, Jose Nativí, D. Budge, Feras Bader, Rami Alharethi, B.B. Reid, Craig H. Selzman, Melanie D. Everitt, Abdallah G. Kfoury, Josef Stehlik

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A&gt;G

    Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A&gt;G 由 Kirsi Majamaa‐Voltti, Keijo Peuhkurinen, Marja‐Leena Kortelainen, Ilmo E. Hassinen, Kari Majamaa

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Beta<sub>1</sub>‐adrenergic receptor gene polymorphisms and response to Beta<sub>1</sub>‐adrenergic receptor blockade in patients with essential hypertension

    Beta<sub>1</sub>‐adrenergic receptor gene polymorphisms and response to Beta<sub>1</sub>‐adrenergic receptor blockade in patients with essential hypertension 由 Jacob Karlsson, Lars Lind, Pär Hallberg, Karl Michaëlsson, Lisa Kurland, Thomas Kahan, Karin Malmqvist, K. Peter Öhman, Fredrik H. Nyström, Håkan Melhus

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Hypertrophic response of the Association of Thyroid Hormone and Exercise in the Heart of Rats

    Hypertrophic response of the Association of Thyroid Hormone and Exercise in the Heart of Rats 由 Fernanda Rodrigues de Souza, Elmiro Santos Resende, Leandro Teixeira Paranhos Lopes, Alexandre Gonçalves, Rafaella Chagas, Thiago Montes Fidale, Poliana Rodrigues

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease

    Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease 由 Mohamad Alkhouli, Paul Sandhu, Khlaed Boobes, Kamel Hatahet, Farhan Raza, Yousef Boobes

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  16. 16
    The ‘neuroadrenergic hypothesis’ in hypertension: current evidence

    The ‘neuroadrenergic hypothesis’ in hypertension: current evidence 由 Guıdo Grassı, Gino Seravalle, Fosca Quarti‐Trevano

    出版 2009
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  17. 17
    Subendocardial Systolic Dysfunction in Asymptomatic Normotensive Diabetic Patients

    Subendocardial Systolic Dysfunction in Asymptomatic Normotensive Diabetic Patients 由 Mami Enomoto, Tomoko Ishizu, Yoshihiro Seo, Masayoshi Yamamoto, Hiroaki Suzuki, Hitoshi Shimano, Yasushi Kawakami, Kazutaka Aonuma

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Hypertrophic Cardiomyopathy: How do Mutations Lead to Disease?

    Hypertrophic Cardiomyopathy: How do Mutations Lead to Disease? 由 Júlia Daher Carneiro Marsiglia, Alexandre C. Pereira

    出版 2014
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  19. 19
    Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients

    Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients 由 I. Pham, E. Cosson, M.T. Nguyen, I. Banu, Isabelle Genevois, Patricia Poignard, Paul Valensi

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Transforming growth factor β<sub>1</sub> genotype and change in left ventricular mass during antihypertensive treatment–results from the swedish irbesartan left ventricular hypertrophy investigation versus atenolol (Silvhia)

    Transforming growth factor β<sub>1</sub> genotype and change in left ventricular mass during antihypertensive treatment–results from the swedish irbesartan left ventricular hypertr... 由 Pär Hallberg, Lars Lind, Katarina Billberger, Karl Michaëlsson, Julia Karlsson, Lisa Kurland, Thomas Kahan, Karin Malmqvist, K. Peter Öhman, Fredrik H. Nyström, Ulrika Liljedahl, Ann‐Christine Syvänen, Håkan Melhus

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: